Literature DB >> 19755289

Comparison of the in vitro performance of 6 and 7 French aspiration catheters.

Hisao Hara1, Masato Nakamura, Hirotaka Komatsu, Nobutaka Ikeda, Hideo Shinji, Kunihiko Makino, Hideki Itaya, Masaya Yamamoto, Naoki Itou, Taro Tsunoda, Kaoru Sugi.   

Abstract

OBJECTIVE: A comparison of aspiration catheters that have been approved for real-world use was carried out in vitro.
BACKGROUND: Myocardial damage occurs during therapeutic aspiration of thrombus. The relative efficiency of aspiration may be important in this regard.
METHODS: Using saline and human clot, nine aspiration catheters were compared Thrombuster III(R)N (6 Fr and 7 Fr), ZEEK (6 Fr), Rebirth (7 Fr), Eliminate (6 Fr and 7 Fr), Pronto (6 Fr), and Export(R) (6 Fr and 7 Fr). Tracking was assessed from the resistance required to pass the catheter through a vessel model. Pushability was determined from the difference between the load at the hand piece and tip of the catheter during advancement through the vessel model.
RESULTS: The Thrombuster III(R)N (6 Fr and 7 Fr) showed significantly better aspiration performance, although the ranking order of the catheters was not the same for saline and clot. The Thrombuster III(R)N also showed the best tracking with low resistance and was the easiest catheter to advance, as evaluated based on pushability.
CONCLUSIONS: In the present in vitro evaluation system, the Thrombuster III(R)N performed better than other catheters.

Entities:  

Year:  2007        PMID: 19755289

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  4 in total

Review 1.  Thrombus aspiration in primary angioplasty for ST-segment elevation myocardial infarction.

Authors:  Roberta Serdoz; Michele Pighi; Nikolaos V Konstantinidis; Ismail Dogu Kilic; Sara Abou-Sherif; Carlo Di Mario
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

2.  ST-elevation myocardial infarction, thrombus aspiration, and different invasive strategies. A TASTE trial substudy.

Authors:  Ole Fröbert; Fredrik Calais; Stefan K James; Bo Lagerqvist
Journal:  J Am Heart Assoc       Date:  2015-06-15       Impact factor: 5.501

3.  CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018.

Authors:  Yukio Ozaki; Yuki Katagiri; Yoshinobu Onuma; Tetsuya Amano; Takashi Muramatsu; Ken Kozuma; Satoru Otsuji; Takafumi Ueno; Nobuo Shiode; Kazuya Kawai; Nobuhiro Tanaka; Kinzo Ueda; Takashi Akasaka; Keiichi Igarashi Hanaoka; Shiro Uemura; Hirotaka Oda; Yoshiaki Katahira; Kazushige Kadota; Eisho Kyo; Katsuhiko Sato; Tadaya Sato; Junya Shite; Koichi Nakao; Masami Nishino; Yutaka Hikichi; Junko Honye; Tetsuo Matsubara; Sumio Mizuno; Toshiya Muramatsu; Taku Inohara; Shun Kohsaka; Ichiro Michishita; Hiroyoshi Yokoi; Patrick W Serruys; Yuji Ikari; Masato Nakamura
Journal:  Cardiovasc Interv Ther       Date:  2018-03-29

Review 4.  CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022.

Authors:  Yukio Ozaki; Hironori Hara; Yoshinobu Onuma; Yuki Katagiri; Tetsuya Amano; Yoshio Kobayashi; Takashi Muramatsu; Hideki Ishii; Ken Kozuma; Nobuhiro Tanaka; Hitoshi Matsuo; Shiro Uemura; Kazushige Kadota; Yutaka Hikichi; Kenichi Tsujita; Junya Ako; Yoshihisa Nakagawa; Yoshihiro Morino; Ichiro Hamanaka; Nobuo Shiode; Junya Shite; Junko Honye; Tetsuo Matsubara; Kazuya Kawai; Yasumi Igarashi; Atsunori Okamura; Takayuki Ogawa; Yoshisato Shibata; Takafumi Tsuji; Junji Yajima; Kaoru Iwabuchi; Nobuo Komatsu; Teruyasu Sugano; Masaru Yamaki; Shinichiro Yamada; Hiroaki Hirase; Yuusuke Miyashita; Fuminobu Yoshimachi; Masakazu Kobayashi; Jiro Aoki; Hirotaka Oda; Yoshiaki Katahira; Kinzo Ueda; Masami Nishino; Koichi Nakao; Ichiro Michishita; Takafumi Ueno; Taku Inohara; Shun Kohsaka; Tevfik F Ismail; Patrick W Serruys; Masato Nakamura; Hiroyoshi Yokoi; Yuji Ikari
Journal:  Cardiovasc Interv Ther       Date:  2022-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.